Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2021-10-14
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For the long-term effects blood markers of cardiometabolic health, blood pressure, body composition, objectively measured physical activity and physical fitness will be assessed before and after the intervention. Also, perceived health-related quality of life will be assessed before and after the intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effective Training in Overweight and Obese People
NCT00218920
Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese
NCT01453972
Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?
NCT00986024
Variety of Physical Activity in Normal to Overweight Adults Who Are Regularly Active
NCT02149147
High Intensity and Moderate Training and Maximal Oxygen Uptake and Activity Levels
NCT01931124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate-repetition resistance training
The participants will undergo a full-body resistance training protocol with moderate repetitions (6-12), moderate load (70-85% of 1RM), and moderate rest between sets (60-90s). Training will be undertaken three times per week.
Moderate-repetition resistance training
Will undertake resistance training with moderate loads, and moderate repetitions 3 times per week for 7 weeks.
High-repetition resistance training
The participants will undergo a full-body resistance training protocol with high repetitions (15+), low load (\<60% of 1RM), and short rest between sets (30s). Training will be undertaken three times per week.
High-repetition resistance training
Will undertake resistance training with low loads, and high repetitions 3 times per week for 7 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate-repetition resistance training
Will undertake resistance training with moderate loads, and moderate repetitions 3 times per week for 7 weeks.
High-repetition resistance training
Will undertake resistance training with low loads, and high repetitions 3 times per week for 7 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Central obesity (defined according to the International Diabetes Federation).
Exclusion Criteria
* recent cardiac infarction (last 4 weeks)
* uncompensated heart failure
* severe valvular illness
* pulmonary disease
* uncontrolled hypertension
* kidney failure
* orthopaedic/neurological limitations
* cardiomyopathy
* planned operations during the research period
* participation in a parallel study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Øystein Risa
Role: STUDY_DIRECTOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Circulation and Medical Imaging
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
246888
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.